• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Sagent Pharmaceuticals Inc

+ Add to Watchlist


26.5500 USD 0.1900 0.72%

As of 17:20:00 ET on 08/21/2014.

Snapshot for Sagent Pharmaceuticals Inc (SGNT)

Open: 26.2700 Day's Range: 26.1500 - 26.6800 Volume: 130,928
Previous Close: 26.3600 52wk Range: 17.4900 - 27.5680 1-Yr Rtn: +17.69%

Stock Chart for SGNT

No chart data available.
  • SGNT:US 26.5500
  • 1D
  • 1M
  • 1Y
Interactive SGNT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SGNT

Current P/E Ratio (ttm) 62.3073
Estimated P/E(12/2014) 102.9070
Relative P/E vs. SPX 3.4941
Earnings Per Share (USD) (ttm) 0.4261
Est. EPS (USD) (12/2014) 0.2580
Est. PEG Ratio -
Market Cap (M USD) 846.86
Shares Outstanding (M) 31.90
30 Day Average Volume 183,218
Price/Book (mrq) 3.4332
Price/Sale (ttm) 3.1116
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SGNT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SGNT

Sagent Pharmaceuticals Inc. is an injectable pharmaceutical company. The Company offers its customers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags.

Jeffrey M YordonChairman/CEOJames M HusseyPresident
Jonathon M SingerExec VP/CFOMichael LogerfoExec VP/Chief Legal Ofcr/Secy
More Company Profile & Key Executives for SGNT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil